Information Library
Central Nervous System (CNS) - Product Development & Commercialization
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by:
- Most Recent
- Title
-
Anticipating the Challenge
March 3, 2010
Extensive experience and expertise in Alzheimer's Disease accelerated outcomes in multi-country Phase II study. -
Advancing Innovation
March 3, 2010
Prescreening and safety measures simplified a Phase II study of a four-dose vaccine that required multiple rating scales. -
Alzheimer's Inroads
March 3, 2010
A global, multi-site Phase III trial required a large number of patients with a specific number of sites and patients at each site. -
Sub-Saharan Africa Phase II/III Fact Sheet
July 29, 2009
Sub-Saharan Africa fact sheet about Phase II/III trials. The gateway to Africa: Access to expanded clinical resources and patient populations in South Africa and beyond.
Page 1 of 1 (4 results)